CF PharmTech repurchases 11,500 H-shares, expanding treasury stock to 699,000 units

Bulletin Express05-08

CF PharmTech, Inc. disclosed that it bought back 11,500 H-shares on 08 May 2026 through on-exchange transactions, paying a total of HKD 0.25 million at prices between HKD 21.58 and HKD 21.90 per share (volume-weighted average: HKD 21.75).

The repurchase reduced the company’s outstanding share count (excluding treasury shares) by 0.0038 % to 301.52 million shares. Treasury holdings increased from 687,500 to 699,000 shares, while total issued shares remained unchanged at 302.22 million.

The buyback forms part of a mandate approved on 16 December 2025 that authorises repurchases of up to 30.22 million shares. To date, 699,000 shares—equivalent to 0.2313 % of the issued share base at the time of the mandate—have been repurchased under this authority.

Under Hong Kong listing rules, CF PharmTech is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares, lasting until 07 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1133099021?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-08 18:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133099021","market":"us","top_or_hot":-1,"title":"CF PharmTech repurchases 11,500 H-shares, expanding treasury stock to 699,000 units","media":"Bulletin Express","content":"<p>CF PharmTech, Inc. disclosed that it bought back 11,500 H-shares on 08 May 2026 through on-exchange transactions, paying a total of HKD 0.25 million at prices between HKD 21.58 and HKD 21.90 per share (volume-weighted average: HKD 21.75).</p>\n<p>The repurchase reduced the company’s outstanding share count (excluding treasury shares) by 0.0038 % to 301.52 million shares. Treasury holdings increased from 687,500 to 699,000 shares, while total issued shares remained unchanged at 302.22 million.</p>\n<p>The buyback forms part of a mandate approved on 16 December 2025 that authorises repurchases of up to 30.22 million shares. To date, 699,000 shares—equivalent to 0.2313 % of the issued share base at the time of the mandate—have been repurchased under this authority.</p>\n<p>Under Hong Kong listing rules, CF PharmTech is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares, lasting until 07 June 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF PharmTech repurchases 11,500 H-shares, expanding treasury stock to 699,000 units</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF PharmTech repurchases 11,500 H-shares, expanding treasury stock to 699,000 units\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-08 18:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CF PharmTech, Inc. disclosed that it bought back 11,500 H-shares on 08 May 2026 through on-exchange transactions, paying a total of HKD 0.25 million at prices between HKD 21.58 and HKD 21.90 per share (volume-weighted average: HKD 21.75).</p>\n<p>The repurchase reduced the company’s outstanding share count (excluding treasury shares) by 0.0038 % to 301.52 million shares. Treasury holdings increased from 687,500 to 699,000 shares, while total issued shares remained unchanged at 302.22 million.</p>\n<p>The buyback forms part of a mandate approved on 16 December 2025 that authorises repurchases of up to 30.22 million shares. To date, 699,000 shares—equivalent to 0.2313 % of the issued share base at the time of the mandate—have been repurchased under this authority.</p>\n<p>Under Hong Kong listing rules, CF PharmTech is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares, lasting until 07 June 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02652","symbol_name":"长风药业","start_time":0,"source_url":"","article_id":"1133099021","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133099021","pubTimestamp":1778237029,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CF PharmTech, Inc. disclosed that it bought back 11,500 H-shares on 08 May 2026 through on-exchange transactions, paying a total of HKD 0.25 million at prices between HKD 21.58 and HKD 21.90 per...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02652":"长风药业"},"translate_title":"CF PharmTech回购11,500股H股，库存股扩大至699,000股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02652":1},"content_text":"CF PharmTech, Inc. disclosed that it bought back 11,500 H-shares on 08 May 2026 through on-exchange transactions, paying a total of HKD 0.25 million at prices between HKD 21.58 and HKD 21.90 per share (volume-weighted average: HKD 21.75).\nThe repurchase reduced the company’s outstanding share count (excluding treasury shares) by 0.0038 % to 301.52 million shares. Treasury holdings increased from 687,500 to 699,000 shares, while total issued shares remained unchanged at 302.22 million.\nThe buyback forms part of a mandate approved on 16 December 2025 that authorises repurchases of up to 30.22 million shares. To date, 699,000 shares—equivalent to 0.2313 % of the issued share base at the time of the mandate—have been repurchased under this authority.\nUnder Hong Kong listing rules, CF PharmTech is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares, lasting until 07 June 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1133099021","isCrawlerRequest":true}